Both in Pharmaceuticals
MAIA Biotechnology vs Coya Therapeutics
Over the past year MAIA returned +3.6% and COYA returned −47.4%; their daily moves had a correlation of 0.32.
MAIA +3.6% COYA −47.4%Growth of $1, one year, split-adjusted
| Metric | MAIA | COYA |
|---|---|---|
| Price | $1.14 | $3.08 |
| Market cap | $70.4M | $72.3M |
| Today | +5.56% | −0.96% |
| 1 month | −4.2% | −36.5% |
| 6 months | −15.6% | −27.4% |
| Year to date | −25.5% | −46.9% |
| 1 year | −1.7% | −48.7% |
| Revenue growth (YoY) | — | +49.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −2723.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 9.0× |
| Net cash | $27.6M | $43.2M |
| Dividend yield | — | — |
| Volatility (60d) | 48.7% | 56.9% |
| Short % of float | 6.0% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).